Out of hospital management of LVAD patients during COVID-19 outbreak
- PMID: 32464685
- PMCID: PMC7283816
- DOI: 10.1111/aor.13744
Out of hospital management of LVAD patients during COVID-19 outbreak
Abstract
Coronavirus disease 2019 (COVID-19) is a pandemic touching thousands of people all around the world. Patients supported with left ventricular assist devices (LVADs) are affected by long-standing cardiovascular diseases and subjected to variations of the normal cardiovascular physiology, thus requiring an even closer monitoring during the COVID-19 outbreak. Nevertheless, the COVID-19 pandemic led to a drastic reduction in routine clinical activities and a consequent risk of looser connections between LVAD patients and their referring center. Potential deleterious effects of such a situation can be a delayed recognition of LVAD-related complications, misdiagnosis of COVID-19, and impaired social and psychological well-being for patients and families. As one of the largest LVAD programs worldwide, we designed a sustainable and enforceable telemonitoring algorithm which can be easily adapted to every LVAD center so as to maintain optimal quality of care for LVAD patients during the COVID-19 pandemic.
Keywords: COVID-19; coronavirus; heart failure; left ventricular assist device; mechanical circulatory support.
© 2020 The Authors. Artificial Organs published by International Center for Artificial Organ and Transplantation (ICAOT) and Wiley Periodicals LLC.
Conflict of interest statement
Jasmin S. Hanke is consultant for Abbott. Jan D. Schmitto and Günes Dogan are consultants for Medtronic and Abbott.
Figures
References
-
- Clerkin KJ, Fried JA, Raikhelkar J, Sayer G, Griffin JM, Masoumi A, et al. Coronavirus disease 2019 (COVID‐19) and cardiovascular disease. Circulation. 2020;141:1648–55. - PubMed
-
- Malchesky PS. Our thanks to ALL healthcare workers on the frontlines caring for our most vulnerable. Artif Organs. 2020;44:543–3. - PubMed
-
- Walter C, Fischer F, Hanke JS, Dogan G, Schmitto JD, Haverich A, et al. Infrastructural needs and expected benefits of telemonitoring in left ventricular assist device therapy: results of a qualitative study using expert interviews and focus group discussions with patients. Int J Artif Organs. 2019:391398819893702. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
